Eledon Pharmaceuticals Inc Cash Flow-to-Debt Ratio
Eledon Pharmaceuticals Inc cash flow-to-debt ratio. Eledon Pharmaceuticals Inc (ELDN) has a Cash Flow-to-Debt Ratio of -0.14x as of December 2025, meaning its operating cash flow of $-14.09 Million could theoretically repay 0% of its total liabilities ($100.82 Million) in one year. Check Eledon Pharmaceuticals Inc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Eledon Pharmaceuticals Inc (2012–2025)
Cash flow-to-debt ratio of Eledon Pharmaceuticals Inc from 2012 to 2025. Historical debt coverage capacity for Eledon Pharmaceuticals Inc across 14 annual periods. Also explore net asset growth rate of Eledon Pharmaceuticals Inc to track the company's year-over-year net asset growth rate.
Eledon Pharmaceuticals Inc Cash Flow-to-Debt Ratio by Year (2012–2025)
Eledon Pharmaceuticals Inc cash flow-to-debt ratio by year from 2012 to 2025. Year-by-year debt coverage analysis for Eledon Pharmaceuticals Inc. For the full cash flow conversion analysis, see Eledon Pharmaceuticals Inc (ELDN) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.62x | $-62.34 Million | $100.82 Million | ▲ +22.5% |
| 2024 | -0.80x | $-47.27 Million | $59.27 Million | ▲ +14.3% |
| 2023 | -0.93x | $-39.53 Million | $42.48 Million | ▲ +71.8% |
| 2022 | -3.30x | $-28.42 Million | $8.61 Million | ▲ +25.2% |
| 2021 | -4.41x | $-28.91 Million | $6.55 Million | ▼ -91.1% |
| 2020 | -2.31x | $-15.21 Million | $6.59 Million | ▲ +75.6% |
| 2019 | -9.45x | $-13.86 Million | $1.47 Million | ▼ -101.4% |
| 2018 | -4.69x | $-11.89 Million | $2.53 Million | ▲ +54.8% |
| 2017 | -10.38x | $-14.94 Million | $1.44 Million | ▲ +17.5% |
| 2016 | -12.58x | $-36.52 Million | $2.90 Million | ▼ -90.7% |
| 2015 | -6.60x | $-41.24 Million | $6.25 Million | ▼ -32.5% |
| 2014 | -4.98x | $-21.12 Million | $4.24 Million | ▼ -2716.2% |
| 2013 | -0.18x | $-15.48 Million | $87.55 Million | ▲ +1.8% |
| 2012 | -0.18x | $-9.33 Million | $51.86 Million | — |